OBJECTIVE
The purpose of this study was to determine if ranolazine improves angina in stable coronary patients with persisting symptoms despite maximum recommended dose of amlodipine.
BACKGROUND
Ranolazine is a unique antianginal agent that has been effective in stable angina, but it has not been